Mutual fund investing involves risks including loss of principal. The chart below covers the period from inception of The Fairholme Allocation Fund (December 31, 2010) to December 31, 2013. Past performance information quoted below does not guarantee future results. The investment return and principal value of an investment in The Fairholme Allocation Fund will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance i nformation quoted below. Performance figures assume reinvestment of dividends and capital gains, but do not reflect a 2.00% redemption fee on shares redeemed within 60 days of purchase. Any questions you may have, including most recent month-end performance, can be answered b y calling Shareholder Services at 1.866.202.2263. The S&P 500 Index is a broad-based measurement of changes in the stock market, is used for comparative purposes only, and is not meant to be indicative of The Fairholme Allocation Fund's performance, asset composition, or volatility. The Fairholme Allocation Fund maintains a focused portfolio of investments in a limited number of issuers and does not seek to diversify its investments. This exposes The Fairholme Allocation Fund to the risk of unanticipated industry conditions and risks particular to a single company or the securities of a single company. The Fairholme Allocation Fund's performance may differ markedly from the performance of the S&P 500 Index or the Barclays Capital U.S. Aggregate Bond Index in either up or down market trends. The performance of the S&P 500 Index is shown with all dividends reinvested and does not reflect any reduction in performance for the effects of transaction costs or ma nagement fees. The Barclays Capital U.S. Aggregate Bond Index is an unmanaged market-weighted index comprised of investment grade corporate bonds (rated BBB or better), mortgages, and U.S. Treasury and government agency issues with at least one year to maturity. Investors cannot invest directly in an index. As reflected in its current prospectus dated April 1, 2013, The Fairholme Allocation Fund's expense ratio is 1.01%, which included acquired fund fees and expenses that are incurred indirectly by The Fairholme Allocation Fund as a result of investments in securities issued by one or more investment companies. Effective as of the close of business on February 28, 2013, the sale of shares of The Fairholme Allocation Fund has been suspended to new investors, subject to certain exceptions.
January 29, 2014
To The Shareholders and Directors of The Fairholme Allocation Fund:
The Fairholme Allocation Fund (the "Fund" or "FAAFX" or "Fairholme")(FAAFX) increased 45.51% versus a decrease of 2.03% for the Barclays CapitalU.S. Aggregate Bond Index (the "Barclays Bond Index") and an increase of 32.39% for the S&P 500 Index (the "S&P 500"), respectively, in the one- year period ended December 31, 2013. The following table compares the Fund's performance (after expenses) with that of the Barclays Bond Index and S&P 500, with dividends and distributions reinvested, for the one-year period ended December 31, 2013, and since inception.
As of December 31, 2013, the Fund's core positions are Fannie Mae and Freddie Mac preferred (15%), American International Group common and warrants (NYSE:AIG) (14%), Sears Holdings common (NASDAQ:SHLD) (12%), and Bank of America warrants (10%), Imperial Metals Common (TSX:III) (7%), and Wells Fargo warrants (6%). Cash and equivalents comprise 16% of the Fund. So far, we have yet to prove our Fund's merit against the S&P 500. Yet, we remain optimistic based on the underlying fundamentals of our issuer companies and on the unique characteristics of warrants held. Time will tell.
Bruce R. Berkowitz
Fairholme Capital Management